Corcept Therapeutics Inc. (CORT)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
Today 5:40 PM
View: 
Mahoney David L
Director
Corcept Therapeutics Inc. (CORT) 11-May-21Option Exercise 30,000$4.42$132,600.0015%
201.48K to 231.48K
Today 5:40 PM
View: 
Mahoney David L
Director
Corcept Therapeutics Inc. (CORT) 11-May-21Payment of Exercise 6,484$20.45$132,598.00(3%)
231.48K to 225.0K
27-Apr-21 6:30 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 23-Apr-21Market Sale (Planned) 10,000$24.02$240,219.00(11%)
90.2K to 80.2K
(1%)
16-Apr-21 10:00 PM
View: 
Wilson James N
Director
Corcept Therapeutics Inc. (CORT) 14-Apr-21Disposition (other) 109,483----(5%)
2.19M to 2.08M
16-Apr-21 10:00 PM
View: 
Wilson James N
Director
Corcept Therapeutics Inc. (CORT) 14-Apr-21Payment of Exercise 90,517$22.95$2,077,370.00(4%)
2.28M to 2.19M
16-Apr-21 10:00 PM
View: 
Wilson James N
Director
Corcept Therapeutics Inc. (CORT) 14-Apr-21Option Exercise 200,000$4.42$884,000.0010%
2.08M to 2.28M
16-Apr-21 10:00 PM
View: 
Wilson James N
Director
Corcept Therapeutics Inc. (CORT) 14-Apr-21Acquisition (other) 109,483----6%
1.97M to 2.08M
07-Apr-21 5:20 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 05-Apr-21Market Option Sale (Planned) 7,500$24.14$181,036.00(100%)
7.5K to 0
07-Apr-21 5:20 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 05-Apr-21Option Exercise 7,500$6.55$49,125.00100%
0 to 7.5K
05-Apr-21 5:12 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 01-Apr-21Market Option Sale 25,000$23.88$597,030.00(100%)
25.0K to 0
05-Apr-21 5:12 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 01-Apr-21Option Exercise 25,000$11.35$283,750.00100%
0 to 25.0K
03-Mar-21 5:38 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 01-Mar-21Market Option Sale 25,000$25.21$630,320.00(100%)
25.0K to 0
03-Mar-21 5:38 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 01-Mar-21Option Exercise 25,000$8.27$206,750.00100%
0 to 25.0K
16-Feb-21 8:50 PM
View: 
Maduck Sean
See Remarks
Corcept Therapeutics Inc. (CORT) 16-Feb-21Market Option Sale 8,989$28.25$253,903.00(15%)
59.01K to 50.02K
< 1%
16-Feb-21 8:50 PM
View: 
Maduck Sean
See Remarks
Corcept Therapeutics Inc. (CORT) 16-Feb-21Option Exercise 8,989$3.29$29,573.8018%
50.02K to 59.01K
16-Feb-21 8:15 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 12-Feb-21Market Sale 112,100$28.22$3,163,900.00(55%)
202.3K to 90.2K
< 1%
16-Feb-21 8:50 PM
View: 
Maduck Sean
See Remarks
Corcept Therapeutics Inc. (CORT) 11-Feb-21Market Option Sale 3,400$29.78$101,249.00(6%)
53.42K to 50.02K
6%
16-Feb-21 8:15 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 11-Feb-21Market Sale 3,400$29.78$101,249.00(2%)
205.7K to 202.3K
6%
16-Feb-21 8:50 PM
View: 
Maduck Sean
See Remarks
Corcept Therapeutics Inc. (CORT) 11-Feb-21Option Exercise 3,400$3.29$11,186.007%
50.02K to 53.42K
04-Feb-21 7:13 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 03-Feb-21Option Exercise 25,000$8.27$206,750.00100%
0 to 25.0K
04-Feb-21 7:13 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 03-Feb-21Market Option Sale 25,000$29.18$729,570.00(100%)
25.0K to 0
4%
26-Jan-21 9:33 PM
View: 
Belanoff Joseph K
Chief Executive Officer
Director
Corcept Therapeutics Inc. (CORT) 22-Jan-21Payment of Exercise 481,088$28.06$13,499,300.00(15%)
3.3M to 2.82M
(< 1%)
26-Jan-21 9:35 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 22-Jan-21Payment of Exercise 258,739$28.06$7,260,220.00(56%)
464.44K to 205.7K
(< 1%)
26-Jan-21 9:33 PM
View: 
Belanoff Joseph K
Chief Executive Officer
Director
Corcept Therapeutics Inc. (CORT) 22-Jan-21Option Exercise 800,000$4.42$3,536,000.0032%
2.5M to 3.3M
26-Jan-21 9:35 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 22-Jan-21Option Exercise 451,852$2.70$1,220,000.003589%
12.59K to 464.44K
21-Jan-21 5:05 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 19-Jan-21Option Exercise 5,000$6.55$32,750.00100%
0 to 5.0K
21-Jan-21 5:05 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 19-Jan-21Market Option Sale (Planned) 5,000$28.74$143,686.00(100%)
5.0K to 0
2%
04-Jan-21 7:43 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 04-Jan-21Option Exercise 25,000$8.27$206,750.00100%
0 to 25.0K
04-Jan-21 7:43 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 04-Jan-21Market Option Sale 25,000$26.13$653,345.00(100%)
25.0K to 0
(7%)
04-Jan-21 7:43 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 30-Dec-20Option Exercise 25,000$7.54$188,457.00100%
0 to 25.0K
04-Jan-21 7:43 PM
View: 
Lyon Joseph Douglas
Chief Accounting Officer
Corcept Therapeutics Inc. (CORT) 30-Dec-20Market Option Sale 25,000$26.07$651,752.00(100%)
25.0K to 0
(8%)
02-Dec-20 7:41 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 01-Dec-20Market Purchase 68$22.64$1,539.52< 1%
5.16M to 5.16M
24%
02-Dec-20 7:41 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 30-Nov-20Market Purchase 1,109$22.80$25,285.20< 1%
5.16M to 5.16M
23%
30-Nov-20 7:46 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 25-Nov-20Market Purchase 361$22.81$8,232.79< 1%
5.16M to 5.16M
23%
24-Nov-20 8:06 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 24-Nov-20Market Purchase 1,429$22.93$32,765.80< 1%
5.16M to 5.16M
23%
27-Nov-20 4:08 PM
View: 
Hunt Hazel
Chief Scientific Officer
Corcept Therapeutics Inc. (CORT) 24-Nov-20Option Exercise 50,000$3.96$198,000.0025000%
0.2K to 50.2K
27-Nov-20 4:08 PM
View: 
Hunt Hazel
Chief Scientific Officer
Corcept Therapeutics Inc. (CORT) 24-Nov-20Payment of Exercise 31,225$22.88$714,428.00(62%)
50.2K to 18.98K
(23%)
24-Nov-20 8:06 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 23-Nov-20Market Purchase 1,551$22.93$35,561.90< 1%
5.16M to 5.16M
23%
11-Feb-21 10:00 PM
View: 
Wilson James N
Director
Corcept Therapeutics Inc. (CORT) 19-Nov-20Gift 253,712----(11%)
2.22M to 1.97M
19-Nov-20 7:48 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 18-Nov-20Market Purchase 2,372$17.91$42,490.60< 1%
5.15M to 5.16M
57%
17-Nov-20 7:43 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 17-Nov-20Market Purchase 7,883$17.82$140,469.00< 1%
5.15M to 5.15M
58%
17-Nov-20 6:10 PM
View: 
Robb Gary Charles
Chief Financial Officer
Corcept Therapeutics Inc. (CORT) 16-Nov-20Gift 2,487----25%
10.1K to 12.59K
17-Nov-20 7:43 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 13-Nov-20Market Purchase 200$17.94$3,588.00< 1%
5.15M to 5.15M
57%
12-Nov-20 6:07 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 10-Nov-20Market Purchase 15,000$17.71$265,635.00< 1%
5.13M to 5.15M
59%
12-Nov-20 6:07 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 09-Nov-20Market Purchase 3,786$17.96$68,013.20< 1%
5.13M to 5.13M
56%
10-Nov-20 8:21 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 06-Nov-20Market Purchase 13,500$17.98$242,665.00< 1%
5.11M to 5.13M
56%
21-Oct-20 9:08 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 19-Oct-20Option Exercise 5,000$6.55$32,750.00100%
0 to 5.0K
21-Oct-20 9:08 PM
View: 
Swisher Daniel N Jr
Director
Corcept Therapeutics Inc. (CORT) 19-Oct-20Market Option Sale (Planned) 5,000$17.66$88,301.00(100%)
5.0K to 0
(59%)
01-Sep-20 8:26 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 01-Sep-20Market Purchase 25,807$12.50$322,526.00< 1%
5.09M to 5.11M
125%
01-Sep-20 8:26 PM
View: 
Baker G Leonard Jr
Director
Corcept Therapeutics Inc. (CORT) 28-Aug-20Market Purchase 20,444$12.48$255,213.00< 1%
5.07M to 5.09M
125%